2026-06-04 07:39:10
Latest Post
Alembic Pharmaceuticals Appoints Mr. Ramesh Juneja as Executive Vice President - Human Health (Sales and Marketing), India Business
Second Half Recovery Limits Nifty Losses to 78 Points; IT Index Tanks 5.5%
Akums Receives European CEP Approval for Cefpodoxime Proxetil
Tunwal E-Motors Reports Strong FY26 Results; Revenue Surges 55% to ₹276.84 Crore
Sharika Enterprises Enters High-Growth SCADA-ADMS Market with Uttarakhand Grid Modernization Project
Research
Buy Voltas for target of Rs.790 : Kotak Securities PCG
Posted On : 2006-02-01 06:11:40( TIMEZONE : IST )
Kotak Securities Private Client Research has given a Buy rating on Voltas Limited with a target of Rs.790 from the current market price of Rs.670.